Cost-Effectiveness Analysis of Bevacizumab in Combination with PC Regimen Versus PC Regimen in Non-Small Cell Lung Cancer Treatment
May 1, 2014, 00:00 AM
10.1016/j.jval.2014.03.506
https://www.valueinhealthjournal.com/article/S1098-3015(14)00557-9/fulltext
Section Title :
Cancer
Section Order :
1555
First Page :
A87
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)00557-9&doi=10.1016/j.jval.2014.03.506